Form 4: Organogenesis Holdings CEO Sells Shares to Cover Tax Obligations

Organogenesis Holdings CEO, Gary S. Gillheeney, sold a total of 61,200 shares of Class A Common Stock to cover tax obligations arising from a previous stock option exercise.

Summary

• Gary S. Gillheeney, the President and CEO of Organogenesis Holdings Inc., sold 55,615 shares of Class A Common Stock on December 13, 2024, at a weighted average price of $3.36.
• He then sold an additional 5,585 shares on December 16, 2024, at a weighted average price of $3.49.
• These sales were made to cover withholding taxes related to a previous stock option exercise.
• Following these transactions, Mr. Gillheeney beneficially owns 3,039,194 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for executives who exercise stock options. It does not indicate any specific trend in the regenerative medicine industry.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The volume of shares sold is not unusual for an executive at this level.
• The weighted average prices are within the typical range for stock transactions.

Stakeholder Impact

• The stock sales may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small volume of shares sold compared to the total outstanding shares.

Key Dates

Keywords

Organogenesis Holdings, ORGO, Gary S. Gillheeney, stock sale, insider trading, Form 4, executive compensation, tax obligations